The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice

References

• Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F. 2007. Drugs improving insulin resistance for non-αlcoholic fatty liver disease and/or nonalcoholic steatohepatitis. Cochrane Database Syst Rev. CD005166.
   Google Scholar
• Angulo P, Lindor KD. 2002. Treatment of non-alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 16:797–810.
   PubMed Web of Science ®Google Scholar
• Anon. 2010. Tylenol professional product information. Fort Washington (MD): McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc.
   Google Scholar
• Bajt ML, Knight TR, Farhood A, Jaeschke H. 2003. Scavenging peroxynitrite with glutathione promotes regeneration and enhances survival during acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther. 307:67–73.
   PubMed Web of Science ®Google Scholar
• Bajt ML, Ramachandran A, Yan HM, Lebofsky M, Farhood A, Lemasters JJ, Jaeschke H. 2011. Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity. Toxicol Sci. 122:598–605.
   PubMed Web of Science ®Google Scholar
• Bessems JG, Vermeulen NP. 2001. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 31:55–138.
   PubMed Web of Science ®Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR. Jr, Green JL, Rumack BH, Giffin SL. 2010. 2009 annual report of the American association of poison control centers' national poison data system (NPDS): 27th annual report. Clin Toxicol (Phila). 48:979–1178.
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Marzocchi R, Villanova N, Marchesini G. 2004. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract Res Clin Gastroenterol. 18:1105–1116.
   PubMed Web of Science ®Google Scholar
• Choi J, Park K-H, Kim SZ, Shin JH, Jang SI. 2013. The ameliorative effects of l-2-oxothiazolidine-4-carboxylate on acetaminophen-induced hepatotoxicity in mice. Molecules 18:3467–3478.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kim SG, Lee MG. 2006. Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects. J Pharm Sci. 95:2543–2552.
   PubMed Web of Science ®Google Scholar
• Cosic V, Antic S, Pesic M, Tovanovic O, Kundal S, Djordjevic VB. 2001. Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients? Clin Chem Lab Med. 39:818–821.
   PubMed Web of Science ®Google Scholar
• Dai J, Liu M, Ai Q, Lin L, Wu K, Deng X, Jing Y, Jia M, Wan J, Zhang L. 2014. Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury. Chem Biol Interact. 216:34–42.
   PubMed Web of Science ®Google Scholar
• Dambach DM, Durham SK, Laskin JD, Laskin DL. 2006. Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol Appl Pharmacol. 211:157–165.
   PubMed Web of Science ®Google Scholar
• Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS. 2006. Acetaminophen poisoning: an evidence based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 44:1–18.
   Web of Science ®Google Scholar
• Das J, Ghosh J, Manna P, Sil PC. 2010. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology. 269:24–34.
   PubMed Web of Science ®Google Scholar
• Davidson MB, Peters AL. 1997. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 102:99–110.
   PubMed Web of Science ®Google Scholar
• de la Rosa LC, Vrenken TE, Manon B, Buist-Homan M, Faber KN, Moshage H. 2005. Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol Res Pers. 11:340–375.
   Google Scholar
• El-Hassan H, Anwar K, Macanas-Pirard P, Crabtree M, Chow SC, Johnson VL, Lee PC, Hinton RH, Price SC, Kass GE. 2003. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, bax, bid, and caspases. Toxicol Appl Pharmacol. 191:118–129.
   PubMed Web of Science ®Google Scholar
• Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, O'Connor T. 2001. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci. 59:169–177.
   PubMed Web of Science ®Google Scholar
• Ewis SA, Abdel-Rahman MS. 1997. Influence of atenolol and/or metformin on glutathione and magnesium levels in diabetic rats. J Appl Toxicol. 17:409–413.
   PubMed Web of Science ®Google Scholar
• Gelotte CK, Auiler JF, Lynch JM, Temple AR, Slattery JT, Slattery JT. 2007. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Clin Pharmacol Ther. 81:840–848.
   PubMed Web of Science ®Google Scholar
• Gobe GC, Morais C, Vesey DA, Johnson DW. 2013. Use of high-dose erythropoietin for repair after injury: a comparison of outcomes in heart and kidney. J Nephropathol. 2:154–165.
   PubMedGoogle Scholar
• Hadi NR, Swadi AA, Mohammad BI. 2012. Hepatoprotective potential of metformin against methotrexate induced hepatotoxicity. Asian J Exp Biol Sci. 3:110–117.
   Google Scholar
• Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N. 2008. Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 283:13565–13577.
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Wolf CR, Kitteringham N, Powell H, Otto D, Park BK. 2000. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci USA. 97:12741–12745.
   PubMed Web of Science ®Google Scholar
• Jaeschke H. 2003. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 284:G15–G26.
   PubMed Web of Science ®Google Scholar
• James LP, Mayeux PR, Hinson JA. 2003. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos. 31:1499–1506.
   PubMed Web of Science ®Google Scholar
• James LP, McCullough SS, Lamps LW, Hinson JA. 2003. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 75:458–467.
   PubMed Web of Science ®Google Scholar
• Kaplowitz N, Shinohara M, Liu ZX, Han D. 2008. How to protect against acetaminophen: don't ask for JUNK. Gastroenterology. 135:1047–1051.
   PubMed Web of Science ®Google Scholar
• Kim YH, Hwang JH, Kim KS, Noh JR, Choi DH, Kim DK, Tadi S, Yim YH, Choi HS, Lee CH. 2015. Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice. J Hepatol. 63:75–82.
   PubMed Web of Science ®Google Scholar
• Knight TR, Ho YS, Farhood A, Jaeschke H. 2002. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther. 303:468–475.
   PubMed Web of Science ®Google Scholar
• Kon K, Kim JS, Jaeschke H, Lemasters JJ. 2004. Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology. 40:1170–1179.
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, et al. 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 42:1364–1372.
   PubMed Web of Science ®Google Scholar
• Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H. 2000. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci. 54:509–516.
   PubMed Web of Science ®Google Scholar
• Lemasters JJ. 1999. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol. 276:G1–G6.
   PubMed Web of Science ®Google Scholar
• Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. 2000. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med. 6:998–1003.
   PubMed Web of Science ®Google Scholar
• Liu H, Song D, Lee SS. 2001. Role of hemeoxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol: Gastrointest Liver Physiol. 280:68–74.
   Web of Science ®Google Scholar
• McGill Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. 2012. The mechanism underlying acetaminopheninduced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest. 122:1574–1583.
   PubMed Web of Science ®Google Scholar
• Meister A, Anderson ME. 1983. Glutathione. Annu Rev Biochem. 52:711–760.
   PubMed Web of Science ®Google Scholar
• Noto H, Goto A, Tsujimoto T, et al. 2012. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One. 7:e33411.
   PubMed Web of Science ®Google Scholar
• Nourjah P, Ahmad SR, Karwoski C, Willy M. 2006. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 15:398–405.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 70:158–169.
   PubMed Web of Science ®Google Scholar
• Paoletti F, Mocali A. 1990. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Meth. Enzymol. 186:209–220.
   PubMed Web of Science ®Google Scholar
• Poon MKT, Chiu PY, Mak DHF, Ko KM. 2003. Metformin protects against carbon tetrachloride hepatotoxicity in mice. J Pharmacol Sci. 93:501–504.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei M, Baradaran A, Rafieian M. 2013. Plants antioxidants: from laboratory to clinic. J Nephropathol. 2:152–153.
   PubMedGoogle Scholar
• Ramachandran A, Lebofsky M, Weinman SA, Jaeschke H. 2011. The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 251:226–233.
   PubMed Web of Science ®Google Scholar
• Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA. 2005. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther. 312:509–516.
   PubMed Web of Science ®Google Scholar
• Rumack BH, Matthew H. 1975. Acetaminophen poisoning and toxicity. Pediatrics. 55:871–876.
   PubMed Web of Science ®Google Scholar
• Saeedi Saravi SS, Ghazi-Khansari M, Mehr SE, Nobakht M, Mousavi SE, Dehpour AR. 2016. Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy. World J Gastroenterol. 22:4685–4694.
   PubMed Web of Science ®Google Scholar
• Saito C, Zwingmann C, Jaeschke H. 2010. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology. 51:246–254.
   PubMed Web of Science ®Google Scholar
• Schoemaker MH, Ros JE, Homan M, Trautwein C, Liston P, Poelstra K, van Goor H, Jansen PL, Moshage H. 2002. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol. 36:742–750.
   PubMed Web of Science ®Google Scholar
• Spasovski D. 2013. Renal markers for assessment of renal tubular and glomerular dysfunction. J Nephropathol. 2:23–25.
   Google Scholar
• Tavafi M. 2013a. Complexity of diabetic nephropathy pathogenesis and design of investigations. J Renal Inj Prev. 2:59–62.
   PubMedGoogle Scholar
• Tavafi M. 2013b. Diabetic nephropathy and antioxidants. J Nephropathol. 2:20–27.
   PubMedGoogle Scholar
• Vishal RT. 2008. Metformin therapy: benefits beyond glycemic control. Int J Diab Dev Ctries. 27:87–95.
   Google Scholar
• Walker TM, Rhodes PC, Westmoreland C. 2000. The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol in Vitro. 14:475–485.
   PubMed Web of Science ®Google Scholar
• Woudenberg-Vrenken TE, de la Rosa LC, Buist-Homan M, Faber KN, Moshage H. 2013. Metformin protects rat hepatocytes against bile acid-induced apoptosis. PLoS One. 8:e71773.
   PubMed Web of Science ®Google Scholar
• Yazdani I, Ghazi-Khansari M, Saeedi Saravi SS, Nobakht M, Majdani R, Rezayat SM, Mousavi SE, Yari A, Dehpour AR. 2016. Nortriptyline protects testes against germ cell apoptosis and oxidative stress induced by testicular ischaemia/reperfusion. Andrologia. doi:10.1111/and.12605.
   PubMedGoogle Scholar
• Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B. 2006. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol. 26:977–986.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 108:1167–1174.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. 2000. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 192:1001–1014.
   PubMed Web of Science ®Google Scholar